Close Menu

product launch

LOS ANGELES (GenomeWeb News) – Seegene intends to pursue an aggressive partnership strategy to promote adoption of its newly released multiplex real-time PCR technology, officials from the Seoul, Korea-based firm told GenomeWeb Daily News at the American Association of Clinical Chemistry

By Tony Fong
NEW YORK (GenomeWeb News) – Genetic test maker Pinpoint Genomics has moved into commercialization phase with the launch of its first product, a prognostic test for non-small cell lung cancer.

The UK firm which went public last month has developed an instrument about the size of a PC targeting laboratories, both small and large, that may not have the space for a conventional platform.

The real-time, single-molecule sequencing technology firm reported $270,000 in grant revenue for the quarter. Its CEO said during a conference call that the company has an order backlog of 44 PacBio RS systems.

Pages

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.